Cancer Care: Bengaluru Doctors See Increasing Shift to Personalized Treatment | Bengaluru News – Times of India

Bengaluru: Doctors in India are witnessing a shift in cancer care as the one-size-faits-ball approach giving gives way to patient-specific treatment, aid by advances in Targeted therapy, IMUNOOOGY, And Genomic profileing.“Today, the aim is to create individualized and personalized treatment for Each patient. That is going to be the holy Grail,” said Dr Sachin Trivedi, Consultant Medical Oncist At HCGANCER CANTING CANTING CANTING CANTING CANTING CANTING CANTING CANTEN HOM “We’re no longer thinking of patients as a homogenous group. Even one lump of cancer can be different at the top and bottom. Looking at genomic signatures is key.”Oncologists say multidisciplinary treatment – combining modalities A Promising Development, Noted Dr Vijay Agarwal, Professor and Lead Consultant, Medical Oncology, Apollo Hospitals, Bengaluru, is the emergence of “antibody conjugates,” ware chemotherapy Drugs are tagged to antibodies to reduce toxicity and improve efficacy. These are showing results in Breast, Lung, and Cardio-Oncology Cases, He Said.Experts also pointed to newer frontiers in targeted immuno -oncology, particularly car t-cael therapy, which uses genetically modified immune cells to atrocket cance. “With these therapies, we hope Dependence on Surgery will reduce,” Dr agarwal said.Doctors emphasized that outcomes in advanced cancer have already improved. “With targeted therapy and immunotherapy in stage four cancer, survival is better. Today, We Look at Stage 4 Cancer Not as Incurableble but as a Chronic Disease, LIKE DIABETES ERPERTENENESION, WHERETENSION Lifelong, “said dr suresh babu mc, medical oncologist at kidwai.Dr bs ajaikumar, founder and executive Chairman, HCG, said access to advanced therapies is no longer limited to metro cite. “In the past two decades, tier 2 cities have also also had phenomenal access,” He said.Technology & CostsBut cost remains a major challenge. “India today has the best of technologies-robotics, surgery, precision medicine, genomic profileing, immuno-orcology, proton therapy. Jalali, Medical Director and Lead (Neuro-Oncology), Apollo Proton Cancer Center, Chennai.Industry Leaders Added that Technology Plays a Vital Role In Driving This personalized shift. Next-Generation Sequencing is Increasingly Used to Read a PATINT’s DNA to Detect Mutations that Indicate Disease Risks. “One provides a sample such as blood or tissue, and it helps us diagnose conditions early and tailor treatment to a person’s unique genetic mutations,” EXPLANED AnJALI PAIAGER, Clinical Genomics for India, at Premas Life Sciences.Chandru from Foundation Medicine, Roche Diagnostics, Noted that Molecular Testing Ensures The Right Patient Gets the right treatment at the right time. “We focus on patients who come at the metastatic stage – Stage 4 and Beyond,” He said.